期刊文献+

99Tcm-MDP骨显像肝脏异常显影原因分析 被引量:2

Analysis of abnormal liver uptake of 99Tcm-MDP in bone scan
原文传递
导出
摘要 目的 分析99Tcm-MDP全身骨显像肝脏异常显影的可能原因。方法 回顾性分析2013年1月至2015年7月于我院核医学科行99Tcm-MDP全身骨显像患者中肝脏异常显影20例,显像结果与其他影像学检查和(或)病理结果、实验室检查进行对比分析。结果 20例肝脏异常显影的患者中,原发性肝损伤3例、继发性肝损伤17例[其中包括多发性骨髓瘤引发肝功能异常1例,恶性肿瘤化疗后肝功能异常8例,肿瘤肝转移7例(结肠癌肝转移5例、肝癌肝内转移1例、肺癌肝转移1例)、慢性肾衰竭铁剂治疗后肝脏摄取1例]。结论 99Tcm-MDP全身骨显像肝脏异常显影的原因较多,除显像技术原因外,应警惕各种原因导致的肝脏损伤,为患者提前进行临床干预提供一定参考。 Objective To analyze the possible causes of liver uptake in 99Tcm-MDP bone scan. Methods A retrospective analysis was performed on 20 cases of abnormal liver uptake in bone scan in our hospital from January 2013 to July 2015. The results were compared with other imaging examinations and/or pathological findings and laboratory examinations. Results Twenty patients were found to have abnormal liver uptake of the imaging agent, including 3 cases with primary liver injury, 17 cases with secondary liver injury, which include 1 case with multiple myeloma and 7 cases with liver metastasis(5 cases with colorectal cancer, 1 with from hepatocellular carcinoma, 1 case with lung cancer), and 1 case of liver uptake after iron treatment. Conclusion Abnormal liver uptake of 99Tcm-MDP in bone imaging is associated with several reasons; barring technical reasons, we should be alert to the liver injury caused by various reasons to provide reference for patients prior to clinical intervention.
出处 《国际放射医学核医学杂志》 2017年第1期15-18,共4页 International Journal of Radiation Medicine and Nuclear Medicine
基金 国家临床重点专科建设项目(国卫办医函【2013】544号)
关键词 99M锝美罗酸盐 骨显像 肝脏 异常摄取 Technetium Te 99m methylenediphosphonate Bone imaging Liver Abnormal uptake
  • 相关文献

参考文献1

二级参考文献7

  • 1Lear L, Nation RL. , Stupans I. Effects of cyclophosphamide and adriamycin on rat hepatic microsome glucuronidation and lipid peroxidation. Biochemical Pharmacology, 1992,44 (2): 747~ 753.
  • 2Honjo l.Suou T, Hirayama C. Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis. Res Commun Chem Pathol Pharmacol. 1998, 61 (2): 49.
  • 3Ma B, Yeo W, Hui P.et al. Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer-a retrospective review of Chinese patients and comparison with an historic Western series. Radiother Oncol, 2002, 62 (2): 185~1899.
  • 4Sumsullah Khan, Jay J, Ramwani, et al. Hepatocyte toxicity of mechloret hamine and other alkylating anticancer drugs.Biochemical Pharmacology, 1992, 43 (9): 1963~1967.
  • 5Manya T. Mcclure. Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats.BiochemicalPharmacology, 1992, 43 (12): 2655~2658.
  • 6姚光弼.第十一讲 药物性肝病[J].中华消化杂志,1999,19(5):339-342. 被引量:133
  • 7施畅,廖明阳.环磷酰胺与异环磷酰胺致肝毒性机制的比较[J].卫生毒理学杂志,2000,14(2):99-102. 被引量:20

共引文献8

同被引文献4

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部